Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lih-Ling Lin

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2014
TRIL is involved in cytokine production in the brain following Escherichia coli infectionPaulina Wochal, Vijay A K Rathinam, Aisling Dunne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 14, 2016
Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary InflammationMichael J Primiano, Bruce A Lefker, Michael R Bowman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2004
Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritisYuhua Zhang, Jun Xu, Jeremy Levin, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2009
Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole bloodJunjun Wu, Neal Green, Rajeev Hotchandani, et al.
Circulation|June 28, 2022
Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced MyocarditisHan Zhu, Francisco X Galdos, Daniel Lee, et al.
International Immunopharmacology|November 9, 2004
Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzymeYuhua Zhang, Martin Hegen, Jun Xu, et al.
Structure (London, England : 1993)|June 7, 2003
Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzymeKathryn W Underwood, Kevin D Parris, Elizabeth Federico, et al.
Journal of Medicinal Chemistry|August 25, 2007
Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitrilesNeal Green, Yonghan Hu, Kristin Janz, et al.
Rheumatology (Oxford, England)|August 29, 2009
TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokinesJun Kuai, Bernard Gregory, Andrew Hill, et al.
Nature Immunology|August 8, 2019
Publisher Correction: Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissuesMarina Cella, Ramya Gamini, Cristiane Sécca, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2014
TRIL is involved in cytokine production in the brain following Escherichia coli infectionPaulina Wochal, Vijay A K Rathinam, Aisling Dunne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 14, 2016
Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary InflammationMichael J Primiano, Bruce A Lefker, Michael R Bowman, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2004
Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritisYuhua Zhang, Jun Xu, Jeremy Levin, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 2009
Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole bloodJunjun Wu, Neal Green, Rajeev Hotchandani, et al.
Circulation|June 28, 2022
Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced MyocarditisHan Zhu, Francisco X Galdos, Daniel Lee, et al.
International Immunopharmacology|November 9, 2004
Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzymeYuhua Zhang, Martin Hegen, Jun Xu, et al.
Structure (London, England : 1993)|June 7, 2003
Catalytically active MAP KAP kinase 2 structures in complex with staurosporine and ADP reveal differences with the autoinhibited enzymeKathryn W Underwood, Kevin D Parris, Elizabeth Federico, et al.
Journal of Medicinal Chemistry|August 25, 2007
Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitrilesNeal Green, Yonghan Hu, Kristin Janz, et al.
Rheumatology (Oxford, England)|August 29, 2009
TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokinesJun Kuai, Bernard Gregory, Andrew Hill, et al.
Nature Immunology|August 8, 2019
Publisher Correction: Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissuesMarina Cella, Ramya Gamini, Cristiane Sécca, et al.
Pageof 6